Efficacy of a computer based discontinuation strategy to reduce PPI prescriptions: a multicenter cluster-randomized controlled trial.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
07 Dec 2023
07 Dec 2023
Historique:
received:
12
04
2023
accepted:
30
11
2023
medline:
8
12
2023
pubmed:
8
12
2023
entrez:
7
12
2023
Statut:
epublish
Résumé
Deprescribing of inappropriate long-term proton pump inhibitors (PPI) is challenging and there is a lack of useful methods for general practitioners to tackle this. The objective of this randomized controlled trial was to evaluate the effectiveness of the electronic decision aid tool arriba-PPI on reduction of long-term PPI intake. Participants (64.5 ± 12.9 years; 54.4% women) with a PPI intake of at least 6 months were randomized to receive either consultation with arriba-PPI from their general practitioner (n = 1256) or treatment as usual (n = 1131). PPI prescriptions were monitored 6 months before, 6 and 12 months after study initiation. In 49.2% of the consultations with arriba-PPI, the general practitioners and their patients made the decision to reduce or discontinue PPI intake. At 6 months, there was a significant reduction by 22.3% (95% CI 18.55 to 25.98; p < 0.0001) of defined daily doses (DDD) of PPI. A reduction of 3.3% (95% CI - 7.18 to + 0.62) was observed in the control group. At 12 months, the reduction of DDD-PPI remained stable in intervention patients (+ 3.5%, 95% CI - 0.99 to + 8.03), whereas control patients showed a reduction of DDD-PPI (- 10.2%, 95% CI - 6.01 to - 14.33). Consultation with arriba-PPI led to reduced prescription rates of PPI in primary care practices. Arriba-PPI can be a helpful tool for general practitioners to start a conversation with their patients about risks of long-term PPI intake, reduction or deprescribing unnecessary PPI medication.
Identifiants
pubmed: 38062116
doi: 10.1038/s41598-023-48839-2
pii: 10.1038/s41598-023-48839-2
pmc: PMC10703926
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
21633Subventions
Organisme : Gemeinsame Bundesausschuss
ID : 01VSF17025
Informations de copyright
© 2023. The Author(s).
Références
Ther Adv Drug Saf. 2019 Apr 05;10:2042098619838796
pubmed: 31057788
J Hosp Med. 2021 Jul;16(7):417-423
pubmed: 34197307
Aliment Pharmacol Ther. 2006 Sep 15;24(6):945-54
pubmed: 16948806
Health Serv Res. 2022 Jun;57(3):568-578
pubmed: 34859435
BMC Prim Care. 2023 Jan 25;24(1):33
pubmed: 36698061
Trials. 2019 Nov 21;20(1):636
pubmed: 31752978
Qual Prim Care. 2012;20(2):141-8
pubmed: 22824567
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
BMJ Open Gastroenterol. 2021 Feb;8(1):
pubmed: 33589415
Res Social Adm Pharm. 2018 Jan;14(1):18-25
pubmed: 28214150
Gastroenterology. 2010 Oct;139(4):1115-27
pubmed: 20727892
J Gerontol B Psychol Sci Soc Sci. 2018 Sep 20;73(7):e98-e107
pubmed: 29190369
Drugs Aging. 2017 Apr;34(4):265-287
pubmed: 28220380
Patient Educ Couns. 2019 May;102(5):879-887
pubmed: 30578105
BMC Med Res Methodol. 2001;1:6
pubmed: 11459516
Mayo Clin Proc. 2021 Oct;96(10):2540-2549
pubmed: 34607633
Ther Adv Drug Saf. 2018 Oct 20;9(12):687-698
pubmed: 30546863
BMC Geriatr. 2021 May 1;21(1):289
pubmed: 33933030
Can Fam Physician. 2017 May;63(5):354-364
pubmed: 28500192
Eur J Clin Pharmacol. 2021 Dec;77(12):1927-1933
pubmed: 34269841
PRiMER. 2021 Nov 02;5:43
pubmed: 34841218
Implement Sci. 2011 Jul 07;6:70
pubmed: 21736724
Ann Epidemiol. 2021 Mar;55:24-26
pubmed: 33338647
J Pharm Pharm Sci. 2013;16(4):511-29
pubmed: 24210060
J Clin Epidemiol. 1989;42(11):1097-105
pubmed: 2809664
BMJ. 2001 Nov 10;323(7321):1123-4
pubmed: 11701584
BMC Pharmacol Toxicol. 2021 Apr 16;22(1):20
pubmed: 33863393
Ir J Med Sci. 2010 Mar;179(1):73-5
pubmed: 19763673
Trials. 2019 Jan 11;20(1):43
pubmed: 30635021
J Clin Pharm Ther. 2000 Oct;25(5):333-40
pubmed: 11123484
Therap Adv Gastroenterol. 2020 Mar 19;13:1756284820913743
pubmed: 32218806
Z Gastroenterol. 2017 Feb;55(2):167-206
pubmed: 27919112
Gastroenterology. 2001 Nov;121(5):1095-100
pubmed: 11677201
Curr Treat Options Gastroenterol. 2020;18(4):557-573
pubmed: 33199955
Pharmacol Res. 2009 Mar;59(3):135-53
pubmed: 18977444
BMC Med Res Methodol. 2020 Jan 6;20(1):3
pubmed: 31906857
Clin Epidemiol. 2017 Mar 15;9:157-166
pubmed: 28352203
Int J Mol Sci. 2019 Nov 02;20(21):
pubmed: 31684070
Aliment Pharmacol Ther. 2011 Sep;34(6):618-27
pubmed: 21770991
Patient. 2018 Feb;11(1):17-28
pubmed: 28608038
Eur J Clin Pharmacol. 2022 Apr;78(4):657-667
pubmed: 34877614
Eur J Gen Pract. 2014 Sep;20(3):174-80
pubmed: 24219345
Eur J Clin Pharmacol. 2007 Aug;63(8):783-90
pubmed: 17549465
Br J Clin Pharmacol. 2016 Sep;82(3):583-623
pubmed: 27077231
JAMA. 1990 Jan 26;263(4):549-56
pubmed: 2104640
Gastroenterology. 2017 Mar;152(4):706-715
pubmed: 28257716
Aliment Pharmacol Ther. 2003 Jun 15;17(12):1503-6
pubmed: 12823152
Am J Gastroenterol. 2013 Mar;108(3):308-28; quiz 329
pubmed: 23419381
Z Gastroenterol. 2014 Nov;52(11):1299-346
pubmed: 25390216
BMC Fam Pract. 2020 Aug 8;21(1):160
pubmed: 32770959
BJGP Open. 2019 Oct 29;3(3):
pubmed: 31581112
Br J Gen Pract. 2001 Sep;51(470):703-11
pubmed: 11593830